Table 1.
Patients’ general characteristics, and clinical parameters at baseline.
| SARS-CoV2 Infection | ||
|---|---|---|
| Negative (n = 65) |
Positive (n = 108) |
|
| Age, years | 58 ± 12.9 | 60 ± 13.1 |
| Gender | ||
| Male | 32 (49.2%) | 75 (69.4%) |
| Female | 33 (50.8%) | 33 (30.6%) |
| BMI, kg/m2 | 28.2 ± 4.9 | 27.9 ± 4.3 |
| Smoke | ||
| Yes | 5 (7.7%) | 3 (2.8%) |
| No | 60 (92.3%) | 90 (83.3%) |
| Missing | - | 15 (13.9%) |
| TC, mg/dL | 207.3 ± 35.9 | 138.1 ± 46.5 |
| LDL-c, mg/dL | 123.8 ± 6.6 | 78.0 ± 24.6 |
| HDL-c, mg/dL | 60.4 ± 14.3 | 27.1 ± 9.7 |
| non-HDL-c, mg/dL | 147.0 ± 36.8 | 110.9 ± 44.5 |
| Triglyceride, mg/dL | 116.7 ± 72.5 | 165.9 ± 62.5 |
| Antihypertensive medications | ||
| Yes | 11 (16.9%) | 16 (14.8%) |
| No | 54 (83.1%) | 92 (85.2%) |
BMI, body mass index; TC, total cholesterol; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol.